Location History:
- Edison, NJ (US) (2006 - 2012)
- New Haven, CT (US) (2012)
Company Filing History:
6 out of 1,829 
3 out of 53 
Years Active: 2006-2012
Title: **The Innovative Path of Wanli Wu: A Pioneer in Pharmaceutical Research**
Introduction
Wanli Wu, an accomplished inventor based in Edison, NJ, has made significant contributions to the field of pharmaceutical research. With a total of six patents to his name, his work primarily focuses on developing novel compounds to combat viral infections. Wu's research not only enhances the understanding of viral mechanisms but also offers potential therapeutic solutions for patients around the world.
Latest Patents
Among his notable inventions, Wanli Wu has two latest patents that stand out. The first patent pertains to "Peptides as NS3-serine protease inhibitors of hepatitis C virus". This invention discloses novel compounds that possess HCV protease inhibitory activity, alongside methods for preparing these compounds. Additionally, the invention provides pharmaceutical compositions comprising such compounds and outlines methods of using them to treat disorders associated with the HCV protease.
His second patent is titled "2,3-substituted indole derivatives for treating viral infections". This invention relates to 2,3-substituted indole derivatives, along with compositions containing at least one such derivative, and methods for utilizing these compounds to treat or prevent viral infections or virus-related disorders in patients.
Career Highlights
Wanli Wu has worked with esteemed organizations such as Schering Corporation and Dendreon Corporation. His experience in these companies has bolstered his innovative capacity, allowing him to contribute significantly to the development of therapeutic agents targeted at viral diseases.
Collaborations
Throughout his career, Wanli Wu has collaborated with notable individuals, including F. George Njoroge and Srikanth Venkatraman. These collaborations have undoubtedly enriched his research endeavors and contributed to the collective advancement of pharmaceutical sciences.
Conclusion
Wanli Wu's commitment to innovation in the pharmaceutical sector is evident through his patents and collaborative efforts. As a dedicated inventor, he continuously seeks to improve treatments for viral infections, showcasing the essential role of inventors in advancing public health. His work stands as a testament to the power of creativity and dedication in the scientific community.